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Interactions between active-site-serine flactamases and mechanism-based
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The interactions between three class A ,-lactamases and three ,-
lactamase inactivators (clavulanic acid, sulbactam and olivanic
acid MM13902) were studied. Interestingly, the interaction
between the Streptomyces cacaoi /J-lactamase and clavulanate
indicated little irreversible inactivation. With sulbactam, irre-
versible inactivation was found to occur with the three studied
enzymes, but no evidence for transiently inactivated adducts was
found. Irreversible inactivation of the S. albus G and S. cacaoi
enzymes was particularly slow. With olivanate, irreversible
INTRODUCTION
,B-lactamases generally catalyse the hydrolysis of the ,-lactam-
ring amide bond in penicillins and related antibiotics with high
efficiency. This reaction gives rise to biologically inactive products
and represents the most widespread mechanism ofresistance that
bacteria have devised to escape the lethal action of that family of
compounds [for reviews, see Frere et al. (1991) and Waley
(1992)].
Most /3-lactamases contain a reactive serine hydroxy group at
the active site (serine enzymes) and are divided in three classes
(A, C and D) on a structural basis (Ambler, 1980; Jaurin and
Grundstrom, 1981; Huovinen et al., 1988; Joris et al., 1991).
Despite their structural diversity, all these enzymes catalyse al-
lactam opening through the formation of an acyl-enzyme
intermediate (Frere et al., 1991; Waley, 1992). Class B contains
a small number of /3-lactamases that require a zinc ion for
activity (Zn2+ enzymes). Their mechanism of action is still poorly
understood.
Since the first report in 1940 entitled 'An enzyme from bacteria
able to destroy penicillin' (Abraham and Chain, 1940), enormous
and continuing efforts have been devoted to obtaining molecules
which would not be affected by the ,?-lactamases of pathogenic
strains. So far two strategies have been developed to overcome
the destructive action of ,?-lactamases. The first is based on the
use of /8-lactams that are resistant to the hydrolytic action of ,-
lactamases while retaining antibacterial activity. The second
utilizes two /J-lactams in synergy: one is a potent inactivator
of the ,-lactamase, but a poor antibiotic, while the other is a
good antibiotic, but is sensitive to the ,3-lactamase action. The
former protects the latter from rapid hydrolysis by the enzyme.
The first strategy tends to avoid the enzyme, and the second
neutralizes it (Knowles, 1985). The second strategy seems to
be the most effective, since ,)-lactamase-resistant molecules
were generally found to be poorer antibiotics (Knowles,
1985).
Although a few non-,/-lactam inhibitors have been described,
namely boronic acids (Kiener and Waley, 1978), most of the ,3-
lactamase inhibitors are 8-lactams. They can be largely con-
inactivation was also observed with the three enzymes, but with
the S. cacaoi enzyme, no hydrolysis could be detected. A tentative
summary of the results found in the literature is also presented
(including 6,8-halogenopenicillanates), and the general con-
clusions underline the diversity of the mechanisms and the wide
variations of the rate constants observed when class A ,-
lactamases interact with /3-lactamase inactivators, in agreement
with the behaviours of the same enzymes towards their good and
poor substrates.
sidered as mechanism-based inhibitors (also known as 'suicide
inhibitors' or 'suicide substrates') insofar as they are substrate-
like reagents whose reactivity is strongly enhanced by a specific
interaction with the enzyme, which can thus be considered as
'committing suicide'. Such a behaviour clearly distinguishes
these compounds from active-site-directed inhibitors [for an
exhaustive review on mechanism-based inhibitors, see Tipton
(1989)]. The fl-lactamase recognizes the inhibitor as a normal
substrate and catalyses the opening of the ,?-lactam ring. The
enzyme is then transiently or definitely inactivated as a stable
covalent adduct (acyl-enzyme). Inhibition is an alternative to
turnover (Cartwright and Waley, 1983). However, it must be
stressed that, owing to the large diversity of ,B-lactamases, there
are significant differences in the interaction of any given com-
pound with different /J-lactamases (Fink, 1985; Pratt, 1989). For
example, penicillanic acid was found to be a good substrate for
the fi-lactamases from Streptomyces albus G and Actinomadura
R39, while it behaved as an inactivator towards the Streptomyces
cacaoi enzyme (Matagne et al., 1990). Moreover, the detailed
mechanism by which a given ,3-lactamase is inhibited by various
,8-lactams can also be very different, even if the final result is the
formation of a stable covalent complex at the acyl-enzyme stage
or a derivative of that intermediate.
In other contributions (Matagne et al., 1993 a,b), we describe
the interactions between various class A 8-lactamases and
compounds which are usually considered as '/,-lactamase-stable'
and which might thus reach their DD-peptidases targets while
escaping the destructive activity of /,-lactamases (first strategy).
The present paper is devoted to compounds which have generally
little antibiotic activity by themselves: they react with the DD-
peptidases slowly or not at all. However, they behave as
mechanism-based inactivators of several active-site-serine ,-
lactamases and are therefore able to potentiate the action of
classical /3-lactamase-sensitive compounds by protecting them
from enzymic hydrolysis (second strategy). Here, we have ana-
lysed the interactions between clavulanic acid, sulbactam and an
olivanic acid with the three class A ,-lactamases produced by
Actinomadura R39, Streptomyces albus G and Streptomyces
cacaoi.
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MATERIALS AND METHODS
Enzymes
Actinomadura R39, Streptomyces albus G and Streptomyces
cacaoi ,-lactamase preparations were those used for the study of
the substrate profiles (Matagne et al., 1990).
Compounds
Sulbactam was from Pfizer Central Research (Sandwich, Kent,
U.K.), and clavulanic acid and olivanic acid MM13902 were
from Beecham Pharmaceuticals (Brentford, Middx., U.K.).
These compounds were kindly given by the respective companies.
Nitrocefin was purchased from Oxoid (Basingstoke, Hants,
U.K.). The structures of the various compounds are shown in
Figure 1.
Determination of the kinetic parameters
fl-Lactamases hydrolyse 'normal' substrates according to the
linear pathway described by Model 1:
E+C k EC-EC -3E+Pk-1
Model 1
More complex interactions involve rearrangements of the
initially formed acyl-enzyme EC* (Model 2a):




When k3 = 0 or k3 << k4, C behaves as a substrate, and all the












Sulbactam Olivanic acids (epithienamycins)
MM 22382, R=H; MM 13902, R=SO3-
EC** (Model 2a'). Irreversible inactivation of the enzyme occurs
ifk3 = k5 =0 (Model 2b) or if k5 = 0 (Model 2c).
Among the interactions which have been studied so far, those
between clavulanic acid and class A enzymes (TEM-2, Klebsiella
pneumoniae E70 and Actinomadura R39) appeared to be even








In this model, EC* might represent an already rearranged
acyl-enzyme. The fate of the second (rearranged) acyl-enzyme,
EC**, is not always clear, and it might undergo direct hydrolysis
(k5), back-rearrangement to EC* (k-4) or both. It is usually
impossible to distinguish between the k4 and k. steps. Arbitrarily,
the situation will be further analysed assuming that k-4 = 0.
Previous studies indicated that Model 2b was probably valid
for the interaction between fl-iodopenicillanate and the S. cacaoi
,8-lactamase (Lenzini and Frere, 1985) and Model 2c for the
interaction between the same compound and the Actinomadura
R39, S. albus G and Bacillus licheniformis enzymes (Frere et al.,
1982a; De Meester et al., 1989). Models 2a and 2b were also
encountered in the study of '/3-lactamase-stable' compounds
(Matagne et al., 1993a,b).
In Model 2c, the ratio between the rate constants (k3/k4),
Waley's (1980) partition ratio, represents the ratio between the
number of productive turnovers and those leading to irreversible
enzyme inactivation. It is determined from experiments where
[C]O/[E]O ([C]0 and [E]0 are the initial concentrations of inhibitor
and enzyme respectively) is such that incomplete inactivation
occurs. The remaining enzyme activity is measured for various
[C]O/[E]O values and the partition ratio deduced from the fol-
lowing relationship (Frere et al., 1982b; Tipton, 1989):
([E]o- [ECi])/[E]o = 1 -[k4/(k3 + 4)] * [C]o/[E]O (1)
When, as observed in the present study, inactivation phenom-
ena consistently obey pseudo-first-order time courses, it can be
safely assumed that k2 4 k-1 and the first step can be considered
as a rapid equilibrium with K=k=llk+,-
Providing that k3 > k4, conditions can then be chosen where
one branch of the pathway has negligible effects on the other,
and the values of kcat Km, k2/K and (ki)iim are computed as
described previously (Frere et al., 1982b). Under conditions
where hydrolysis can be neglected ([C]O/[E]o > k3/k4), enzyme




Km = k3 *K/(k2+k3+k4)
and
(ki)lim = k2 *k4/(k2+k3+k4)
and thus














kcat = k2 k3/(k2+ k3+k4)
Experimental conditions
(6) Kinetic experiments were all performed under the conditions
described for the study of 'fl-lactamase-stable' compounds
(Matagne et al., 1993 a,b). Hydrolysis of sulbactam and olivanic
(7) acid were recorded directly at 235 nm and 304 nm respectively.
Note that K. and keat are nearly identical with those of the
simple linear pathway if k3 > k4.
In this mechanism, (ki)iim is a first-order rate constant
characterizing the rate of the inactivation process at saturating
inactivator concentrations. Inactivation rate constants (k1) can
be measured in the presence of a reporter substrate, as described
by De Meester et al. (1987a), or directly, if the disappearance of
the inactivator can be monitored. Steady-state parameters (kcat
and Km) values are determined respectively by initial-rate
measurements and competitive-inhibition experiments, per-
formed rapidly, before the inactivation process becomes detect-











Figure 2 Transient Inactivation of the S. cacao! enzyme by clavulanate
Enzyme ([E]O = 1.8 ,uM) was incubated with 5.5 (0) and 10 (0) molar proportions of




Clavulanic acid, a naturally occurring fl-lactam, shows weak
antibacterial activity, but displays potent ,6-lactamase inhibitory
properties (Brown et al., 1976). In combination with amoxycillin
(Augmentin), it represents a powerful clinical strategy to over-
come the resistance of bacteria harbouring the TEM /J-lactamase
variants capable of hydrolysing third-generation cephalosporins
(Seetulsingh et al., 1991). Yet a recent report (Thomson and
Amyes, 1992) of a clinical isolate carrying a TEM-like enzyme
that confers resistance to Augmentin (TRC-lIl-lactamase) will
certainly disturb the confidence of clinicians.
Clavulanic acid is characterized by an oxazolidine ring, the
absence of acylamino side chain and an unusual substituent on
C-2.
The reactions of the f6-lactamases of Actinomadura R39 and S.
albus G with clavulanate proceed along branched pathways
(Frere et al., 1982b). Conversely, a simple linear pathway has
been proposed for the S. cacaoi enzyme (Ogawara and Mantoku,
1981). However, our results indicated a more complex interaction.
At low [C]O/[E]o ratios, a transient inactivation was observed,
followed by a complete recovery of the enzyme activity (Figure
2). Longer incubations (24-48 h) with high [C]O/[E]o ratios (up to
15000) resulted in a low level of irreversible inactivation; after
exhaustive dialysis at 4 °C and a further 2 h incubation at 30 °C
to re-activate any transiently inactivated enzyme, the activity was
not completely recovered, but the irreversible loss of activity did
not exceed 20-30%. Although these results indicated the validity
of Model 3, the value of k6 was so low (< 3 x 10-5 s-1) as to make
Table 1 Kinetic parameters of I8-lactamases for sulbactam
Notes: (a) measured directly under initial-rate conditions; (b) measured by monitoring the hydrolysis of sulbactam itself; (c) measured by the reporter substrate method; (d) calculated from the
individual A6t and (k),im values; (e) measured directly in partial inactivation experiments (eqn. 1); (f) measured as K1 (S. albus G, S. cacaoI) or from the curves ki versus [C] (Actinomadura
R39); (g) and (h) calculated from individual values.
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Interaction between the Actinomadura R39 pI-lactamase and
(a) Variation of k, with [C] at low sulbactam concentrations from which a (ki)Iim/Km value of
430 M-' - s-1 could be obtained; (b) saturation phenomenon at larger concentrations [the
data were fitted to eqn. (2)]; (c) Hanes plot of the data in (b) allowing the computation of
(ki)iim = 0.0084 s-1 and Km = 7.2 ,uM.
it irrelevant in in vivo situations, and Model 2a appears to be
more relevant. A detailed kinetic analysis of that complex
interaction is beyond the scope of the present study and remains
the subject of further investigation.
Sulbactam (penicillanic acid sulphone)
Sulbactam (CP 45899), first reported by English et al. (1978), is
obtained by oxidation of the thiazolidine sulphur of penicillanic
acid and is used in combination with ampicillin for clinical
application.
In contrast with results obtained, for instance, with the TEM-
2 /?-lactamase by Knowles and colleagues (Brenner and Knowles,
1981; Kemal and Knowles, 1981; Brenner and Knowles, 1984),
which indicated the validity of Model 3, no evidence for
transiently inactivated adducts was found with the three enzymes
studied here and the experimental data were analysed on the
basis of Model 2c, yielding the values shown in Table 1.
The partition ratio, k3/k4, was measured in partial-inactivation
experiments with the help of eqn. (1). The partially inactivated
samples, when left at 15 °C for 48 h, did not exhibit any activity
recovery.
Directly monitoring the hydrolysis of sulbactam at 235 nm
and at concentrations much larger than the Km values and than
k3[E]0/k4, yielded the values of k08, (from the initial rates) and
of (ki)iim from the progressive inactivation of the enzyme.
For the S. albus G and S. cacaoi enzymes, with which
inactivation was quite slow, the Km values were measured as K1
values using nitrocefin as substrate. With the Actinomadura R39
enzyme, the reporter-substrate method was used at [C]0/[E]0>
50000 and at low sulbactam concentrations, a (ki),im/Km value of
450+ 50 M-1 * s-I was measured on the basis of the slope of the
linear ki-versus-[sulbactam] plot (Figure 3a). At higher concen-
trations, a hyperbolic dependency was observed from which the
individual values of (ki),im ((8.3 + 0.5) x 10-3 s-1) and Km(7.2-9.7 ,uM) could be derived (Figures 3b and 3c), thus yielding
a somewhat higher (ki)jim/Km value of 1000 + 100 M-1 * s-1.
The hydrolysis of sulbactam by the S. albus G /J-lactamase was
also performed in the presence of 1 M NaCl, yielding a kcat of
1.6 + 0.1 and a (ki)iim of about 3 x 10-5 s-'. Thus the partition
ratio was not dramatically altered by the presence of high salt
concentrations, in contrast with the results obtained with the
same enzyme and fl-halogenopenicillanates (De Meester et al.,
1989).
Olivanic acid MM13902 [(5R,6R)-cis-carbapenem]
Olivanate MM 13902 (epithienamycin E; R = SO3-) is one of the
first carbapenems isolated (Brown et al., 1977). It is characterized
by a sulphate moiety on the 6,8-(a-hydroxyethyl) side chain. The
importance of this group was underlined by the fact that the
analogous compound, MM22382, lacking the sulphate group
(epithienamycin D; R = H), behaved as a good substrate for the
TEM enzyme and was a relatively inefficient inactivator (Charnas
and Knowles, 1981a; Easton and Knowles, 1982).
The S. albus G ,J-lactamase hydrolysed the olivanic acid, but
progressive inactivation occurred. Inactivation was complete
with [C]0/[E]0> 1000. No re-activation of the partially in-
activated samples was observed after 24 h at 20 'C. The initial
rates of hydrolysis were independent of olivanate concentrations
at [C]0 = 50 ,uM and yielded a kcat value of 0.4 + 0.04 s- . Under
the same conditions, the rate of progressive inactivation (meas-
ured either directly or in the presence of a reporter substrate) was
similarly independent of the inactivator concentration, and
yielded a (ki)iim value of (3 + 1) x 10-3 s-1. These data were in
good agreement with Model 2c, but competitions with nitrocefin,
performed under initial-rate conditions, suggested a Km (= Ki)
value of 14,uM. In disagreement with this value, the apparent
first-order rate constant for inactivation (k,) remained inde-
pendent of [C]0 in the 8-20,M range.
Qualitatively, the Actinomadura R39 ,-lactamase behaved as
the S. albus G enzyme, a [C]0/[E]0 value of 100 yielding partial
inactivation. A kcat. value of 0.7+0.1 s-' was observed under
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(8 +2) 10-3 s-' was derived from the rate of progressive inacti-
vation for [C]0 = 100 ,M.
Conversely, the S. cacaoi ,J-lactamase was completely and
rapidly inactivated. At a 0.2,M concentration of olivanate
([C]O/[E]o = 50), a k, value of 0.02 s-' was found. No hydrolysis
could be detected.
DISCUSSION
The data presently available in the literature reveal similarities in
the modes of action of clavulanic acid and sulbactam (Knowles,
1985). In both cases, there are three possible fates for the initially
formed acyl-enzyme (EC*): it can undergo hydrolysis, leading to
free enzyme (E), reversible tautomerization to yield a more stable
species (EC**), leading to transiently inhibited enzyme, or an
irreversible modification into a definitively inactivated enzyme
(ECi*). In the case of sulbactam, this latter complex seemed to be
formed by a transamination reaction with an enzyme lysine
residue, thus resulting in the cross-linking of two active-site
side chains (Brenner & Knowles, 1984). A similar cross-linking
reaction has been proposed for clavulanate, but the experimental
evidence was less convincing. Formation of the initial acyl-
enzyme (EC*) is accompanied by the opening of the C5-01
(clavulanate) or C5-S1 (sulbactam) bonds. Whatever the chemical
mechanism, kinetically the interactions between these inacti-
vators and several enzymes appeared to be well represented by
Model 3, where intramolecular events and a reaction with a
second active-site side chain occur in competition with hydrolytic
deacylation, so that complete inactivation is only accomplished
over a number of turnovers. Model 3 seemed to apply in the
interactions between clavulanate and the TEM-2 (Fisher et al.,
1978; Charnas et al., 1978; Charnas and Knowles, 1981b;
Reading and Farmer, 1981), Klebsiella pneumoniae E70 (class A)
and Proteus mirabilis C889 (undetermined class; Reading and
Farmer, 1981) and the Actinomadura R39 (Frere et al., 1982b) p8-
lactamases and between sulbactam and the TEM-2 (Brenner
and Knowles, 1981; Kemal and Knowles, 1981; Brenner and
Knowles, 1984) and SHV-1 (Labia et al., 1980) fl-lactamases.
This mechanism might not, however, be universal, since no
irreversible inactivation was detected in the reactions between
clavulanate and the ,-lactamases of S. aureus (class A) (Cart-
wright and Coulson, 1979; Reading and Hepburn, 1979; Rizwi
et al., 1989), and Enterobacter cloacae P99 (class C) (Reading
and Farmer, 1981). Also with the S. aureus enzyme, no turnover
occurs before transient inactivation. The interaction between
clavulanate and the S. cacaoi ,J-lactamase seems to offer yet
another variation: the value of k6 is so low that Model 2a better
represents the physiologically important phenomenon.
Several other penam sulphones have also been found to be
inhibitors of f8-lactamases (see, e.g. Cartwright & Coulson, 1979;
Fisher et al., 1981; Kelly et al., 1981; Clarke et al., 1983; Knight
and Waley, 1985). More recently, Fink and colleagues (1989)
observed that inactivation of,-lactamases by penicillin sulphones
bearing large hydrophobic side chains was accompanied by a
significant change in the protein conformation. They suggested
that the inactivation mechanism might depend upon the structure
of the C-6 side chain. Actually, it appears that the effectiveness
of the sulphone can be modulated through the C-6 and the C-2
substituents (Pratt, 1992).
With the three enzymes studied here, sulbactam seemed to
react according to Model 2c, which is also valid for the interaction
between /8-iodopenicillanate and the Actinomadura R39 and
S. albus G fl-lactamases (see below). However, with the
penicillanates (De Meester et al., 1989). This result strengthens
the conclusion that the salt effect is a specific characteristic of
these latter inactivators (De Meester et al., 1989).
Our results for sulbactam are thus at variance with those of
Knowles (1985), who observed an additional branch responsible
for a transient inactivation (Model 3). However, the existence of
such a branch cannot be ruled out for the enzymes studied here.
A rapid equilibrium between initially formed acyl-enzyme and
the transient inactivated species would render the latter un-
detectable and would just lower the apparent Km and kcat for
hydrolysis. Finally, the kcat and (ki)iim observed for the TEM-2
enzyme fall within the range of those measured here. The
irreversible inactivation of the S. albus G and S. cacaoi enzymes
was particularly slow.
A thorough kinetic study of the interaction between the TEM-
2 fl-lactamase and derivatives of olivanic acid has been presented
by Knowles and co-workers (Charnas and Knowles, 1981a;
Easton and Knowles, 1982). Olivanate MM 13902 was found to
be a poor substrate of the TEM-2 enzyme (the value of the
steady-state turnover rate was 8.5 x 10-4 s-1) and an excellent
inactivator (the value of the apparent second-order rate constant
for the inactivation process was about 106 M-1 s-1). The chemical
events described for clavulanic acid and sulbactam cannot apply
to olivanic acid, for which no rupture of the bond between
positions 1 and 5 occurs, yet chemical diversion from the normal
course of the catalysed hydrolytic reaction also results in trans-
ient enzyme inactivation (Knowles, 1985). The first formed acyl-
enzyme contains a d-2 pyrroline and may either undergo de-
acylation or tautomerize to a more stable d-1 pyrroline. This
competitive process can be described by Model 2a, where the
d-1 pyrroline may deacylate directly (k5 # 0). Alternatively, back
tautomerization to the &-2 pyrroline may occur alone (k4 # 0,
k5 = 0) or in competition with the hydrolytic process (k-4 and
k5 0 0), but, as stated in the Materials and methods section, it is
extremely difficult, if not impossible, to distinguish between these
three possibilities.
Our results with the Actinomadura R39 and S. albus G /3-
lactamases also indicated the occurrence of a branched pathway,
but inactivation appeared to be irreversible, in good agreement
with Model 2c. Re-activation might have been too slow to be
detectable under our experimental conditions. With the S. cacaoi
enzyme, no hydrolysis could be detected, suggesting a somewhat
different model.
Although these compounds have not been studied here, a
discussion of /3-lactamase inactivators would not be complete if
6/-halogenopenicillanates were not mentioned. Indeed, they have
been extremely valuable for labelling and identifying the active
serine residue of many enzymes (Knott-Hunziker et al., 1979;
Cohen & Pratt, 1980; Joris et al., 1984; Joris et al., 1986; Joris
et al., 1987; De Meester et al., 1987b; Amicosante et al., 1988).
They are much more efficient as inactivators of the class A than
the class C enzymes, thus supplying an easy method for disting-
uishing between the two classes (De Meester et al., 1986). With
,/-iodopenicillanate, branched pathways seem to prevail with
some enzymes, while no hydrolysis occurs with others (class C)
(De Meester et al., 1986). Note that, with the Actinomadura R39
enzyme, the published k3/k4 value of 80 (Frere et al., 1982a) must
be corrected to 150, since the former value was computed on the
basis of an erroneous Mr value (15000 as against 29000 deduced
from the amino acid sequence).
The prevalence of Models 2c or 2b depended not only on the
considered enzyme, but also on the nature of the halogen atom
(De Meester et al., 1989). Inactivation was accompanied by the
rearrangement of the penam moiety into a dihydrothiazine
chromophore and the reaction pathway seemed to involve an
latter enzyme, the partition ratio k,,/k4was not influenced by ionic
strength, in contrast with what was observed with fl-halogeno-
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Table 2 Overview of the Interacton between Inactivators and h8-lactamases of classes A and C
The first value in each case refers to the relevant model(s). The first letter refers to the value of kcatKm or k2/K': H > 100000 M1 s-1 > M > 1000 M-1 s- > L > 1 M-1 5s1. The second
letter refers to the rate of re-activation of the transiently inactivated enzyme: 0.1 s1 > S > 10-s0 > 0. References: 1, Brenner and Knowles, 1981; 2, Brenner and Knowles, 1984; 3, Cartwright
and Coulson, 1979; 4, Charnas et al., 1978; 5, Charnas and Knowles, 1981a, 6, Charnas and Knowles, 1981 b; 7, Cohen and Pratt, 1980; 8, De Meester et al., 1986; 9, De Meester et al., 1989;
10, Easton and Knowles, 1982; 11, Fisher et al., 1978; 12, Fisher et al., 1981; 13, Frere et al., 1982a; 14, Frere et al., 1982b; 15, Kemal and Knowles, 1981; 16, Knott-Hunziker et al., 1980;
17, Labia et al., 1980; 18, Lenzini and Frbre, 1985; 19, Pratt and Cahn, 1988; 20, Reading and Hepburn, 1979; 21, Reading and Farmer, 1981; 22, Rizwi et al., 1989; 23, Yamaguchi et at.,
1983.
Actinomadura
Compound R39 S. albus G S. cacaoi TEM-1/2 Other class A Class C References
Clavulanic acid 3 H 0 3/2c H 0 3/2a H 0 3 M 0 3/2a/2'a H S/0 2'a L 0 3, 4, 6, 11, 14, 20, 21, 22
Sulbactam 2c H 0 2c H 0 2c M 0 3 H 0 Irreversible inhibitor* 3 H 0 1, 2, 12,15, 17, 23
6,8-lodopenicillanic 2c H 0 2c H 0 2b M 0 2c H 0 2b/2c M 0 2b L 0 7, 8, 9,13,16,18,19
acid
Olivanic acid NDt M 0 ND M 0 ND H 0 2a H S ND ND ND ND ND ND 5, 10
* Reported without quantitative details.
t ND, not determined (no data).
intermediate episulphonium, without rupture of the C6-C6 bond
(Pratt and Cahn, 1988; De Meester et al., 1989).
This overview of the interactions between class A fl-lactamases
and specific inactivators underlines the diversity ofthe behaviours
of these enzymes, a conclusion which agrees well with their
diverse catalytic properties. Indeed, previous studies show that
'classical' fl-lactams or 'fl-lactamase-stable' compounds can
behave very differently if various enzymes are studied (Matagne
et al., 1990, 1993 a,b).
Table 2 presents a synthesis of the results obtained here and
available in the literature (including 6,-iodopenicillanate). It is
not always easy to distinguish between schemes which only differ
by the presence or absence of one branch (i.e. Model 2a is Model
3 with k6 = 0), and the data in the literature do not always
present detailed analyses. The most striking conclusion is that
class A ,-lactamases behave as a very heterogeneous group in the
presence of their mechanism-based inactivators.
The only safe prediction that can be made seems to be that it
is nearly impossible to infer the exact reaction pathway of a
potential inactivator from the fact that the enzyme belongs to
class A. The recent discovery of clavulanate-resistant TEM
variants also shows that there might be no such thing as an
'universal' class A inactivator (Thomson & Amyes, 1992).
In this study and in the study of 'fl-lactamase-stable' com-
pounds (Matagne et al., 1993 a,b), we have not encountered any
compound whose inactivating potency only rested on a con-
formation change at the level of the acyl-enzyme. These de-
stabilizing substrates, termed A-type substrates by Citri and
colleagues (1976), have received much attention from Citri (Citri
et al., 1976; Klemes and Citri, 1980), Fink (Fink et al., 1987),
Pain and Virden (Virden et al., 1978; Pain and Virden, 1979;
Carrey et al., 1984; Persaud et al., 1986) and Waley (Kiener and
Waley, 1977; Kiener et al., 1980; Thornewell and Waley, 1992)
and their collaborators (see also Hardy and Kirsch, 1989).
Although such modifications of the enzyme structure can cer-
tainly not be ruled out in the various cases encountered here, they
do not appear to represent the sole phenomenon involved in the
loss ofenzyme activity. Interactions with the various compounds
could yet result in corformational changes, confined 'to the
active-site or extended to the bulk tertiary structure of the
studied enzymes. These conformational constraints could
undoubtly contribute to enzyme inactivation and should not be
neglected. It is indeed likely that many of these acyl-enzymes,
derived from extensive rearrangements (obtained, e.g., with
cefoxitin, moxalactam, sulbactam, clavulanic acid or olivanic
acid), are inert for non-covalent (conformational) reasons as well
as covalent (Pratt, 1989, 1992).
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